Compare Stocks → Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:EVENYSE:MDPCNSX:MMJNYSEAMERICAN:ZOM Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEVEEVe Mobility Acquisition$11.01+0.2%$10.92$10.36▼$11.40$171.76M-0.0140,200 shs25,782 shsMDPMeredith$58.78$18.00▼$59.16$2.70B2.07552,848 shs3.36 million shsMMJMatica EnterprisesC$0.00C$0.03▼C$0.64N/AN/A79,508 shs287,225 shsZOMZomedica$0.13-1.1%$0.00$0.12▼$0.25$125.34M15.20 million shs1.46 million shs7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEVEEVe Mobility Acquisition0.00%0.00%+0.23%+1.48%+4.97%MDPMeredith0.00%0.00%0.00%0.00%-16.22%MMJMatica Enterprises0.00%0.00%0.00%0.00%0.00%ZOMZomedica0.00%0.00%+1.67%+4.23%-33.73%Bitcoin Rockets To Record High But Buy THIS Instead (Ad)Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEVEEVe Mobility AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AMDPMeredithN/AN/AN/AN/AN/AN/AN/AN/AMMJMatica EnterprisesN/AN/AN/AN/AN/AN/AN/AN/AZOMZomedicaN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEVEEVe Mobility Acquisition3.00Buy$12.5013.53% UpsideMDPMeredithN/AN/AN/AN/AMMJMatica EnterprisesN/AN/AN/AN/AZOMZomedicaN/AN/AN/AN/ACurrent Analyst RatingsLatest MMJ, ZOM, EVE, and MDP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/21/2024EVEEVe Mobility AcquisitionJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$13.50 ➝ $12.50(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEVEEVe Mobility AcquisitionN/AN/AN/AN/AN/AN/AMDPMeredith$2.98B0.00N/A5.68$14.27 per share0.00MMJMatica EnterprisesN/AN/AN/AN/AN/AN/AZOMZomedica$25.19M4.98N/AN/A$0.24 per share0.53Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEVEEVe Mobility AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/AMDPMeredith$306.60M$5.9010.01N/AN/A9.66%41.72%4.92%N/AMMJMatica EnterprisesN/AN/A0.00N/AN/AN/AN/AN/AN/AZOMZomedica-$34.53M-$0.04N/A∞N/A-137.10%-8.13%-7.68%5/9/2024 (Estimated)Latest MMJ, ZOM, EVE, and MDP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/1/2024Q4 2023ZOMZomedicaN/A-$0.01-$0.01N/A$7.00 million$7.34 million DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEVEEVe Mobility AcquisitionN/AN/AN/AN/AN/AMDPMeredithN/AN/AN/AN/AN/AMMJMatica EnterprisesN/AN/AN/AN/AN/AZOMZomedicaN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEVEEVe Mobility AcquisitionN/AN/AN/AMDPMeredith4.031.391.36MMJMatica EnterprisesN/AN/AN/AZOMZomedicaN/A11.0610.49OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEVEEVe Mobility AcquisitionN/AMDPMeredith78.23%MMJMatica EnterprisesN/AZOMZomedica8.95%Insider OwnershipCompanyInsider OwnershipEVEEVe Mobility Acquisition2.90%MDPMeredith9.79%MMJMatica EnterprisesN/AZOMZomedica4.18%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableEVEEVe Mobility AcquisitionN/A15.60 million15.15 millionNot OptionableMDPMeredith5,33045.78 million41.30 millionOptionableMMJMatica EnterprisesN/AN/AN/ANot OptionableZOMZomedica144979.95 million938.99 millionNot OptionableMMJ, ZOM, EVE, and MDP HeadlinesSourceHeadlineZomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024accesswire.com - April 9 at 6:30 AMZomedica Corp. (AMEX:ZOM) Q4 2023 Earnings Call Transcriptmsn.com - April 2 at 4:06 PMQ4 2023 Zomedica Corp Earnings Callfinance.yahoo.com - April 2 at 8:30 AMZOM Stock Earnings: Zomedica Beats Revenue for Q4 2023investorplace.com - April 1 at 9:06 PMZomedica reports Q4 resultsmsn.com - April 1 at 5:27 PMZomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidityaccesswire.com - April 1 at 4:05 PMThe Next Millionaire-Makers: 3 Penny Stocks With Massive Upside Potentialinvestorplace.com - April 1 at 3:12 PMZomedica to Report Fourth Quarter and Full Year 20…pharmiweb.com - March 20 at 9:17 AMZomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ETaccesswire.com - March 20 at 6:30 AMZomedica Pharmaceuticals Corp (ZOM)investing.com - March 15 at 7:52 AMZomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platformaccesswire.com - March 14 at 6:30 AMZomedica Provides NYSE American Listing Updateaccesswire.com - March 13 at 4:45 PMSidoti & Company, LLC: Sidoti Events, LLC's Virtual March Small-Cap Conferencefinanznachrichten.de - March 12 at 11:26 AMZomedica Corp.: Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferencesfinanznachrichten.de - March 12 at 8:22 AMZomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferencesaccesswire.com - March 12 at 6:30 AMZomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogsaccesswire.com - March 7 at 6:30 AMZomedica to Present at the Sidoti Small Cap Conference March 14, 2024accesswire.com - March 5 at 6:30 AMZomedica Pharmaceuticals Corp. (ZOM)uk.finance.yahoo.com - March 1 at 2:46 PMZomedica Corp.: Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferencesfinanznachrichten.de - February 8 at 9:14 AMZomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferencesfinance.yahoo.com - February 8 at 9:14 AMZomedica Corp.: Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidationfinanznachrichten.de - February 6 at 5:00 PMLeading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split)finance.yahoo.com - February 6 at 5:00 PMZomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ETfinance.yahoo.com - February 6 at 7:00 AMZomedica Corp. (ZOM) Interactive Stock Chart - Yahoo Financefinance.yahoo.com - February 4 at 8:05 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Cheap Stocks That Shouldn’t Be Cheap for Long March 26, 2024 9:49 AMView 3 Cheap Stocks That Shouldn’t Be Cheap for Long 3 Stocks With Unusual Call Option ActivityMarch 26, 2024 1:10 PMView 3 Stocks With Unusual Call Option ActivityNvidia's AI Tech Part of Novo Nordisk's New Supercomputer March 24, 2024 1:50 PMView Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer 2 Data Storage Device Stocks Thriving From the AI BoomApril 2, 2024 7:25 AMView 2 Data Storage Device Stocks Thriving From the AI BoomConsumer Sentiment Highest Since 2021, 3 Stocks Leading the WayApril 1, 2024 9:25 AMView Consumer Sentiment Highest Since 2021, 3 Stocks Leading the WayAll Headlines Company DescriptionsEVe Mobility AcquisitionNYSE:EVEEVe Mobility Acquisition Corp does not have significant operations. The company focuses on effectuating a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. It intends to focus on the automotive and mobility industry. The company was incorporated in 2021 and is based in Wilmington, Delaware.MeredithNYSE:MDPMeredith Corp. engages in television broadcasting and magazine advertising business. It operates through the Local Media and National Media business segments. The Local Media segment includes television stations and offers websites, mobile-optimized websites, and mobile applications. The National Media segment consists of national consumer media brands delivered via multiple media platforms including print magazines and digital and mobile media, brand licensing activities, database-related activities, and business-to-business marketing products and services. The company was founded by Edwin Thomas Meredith in 1902 and is headquartered in Des Moines, IA.Matica EnterprisesCNSX:MMJMatica Enterprises Inc. focuses on medical marijuana business. It also holds interest in the Grumpy Lizard project in Nevada, the United States; and an option agreement to acquire a 100% interest in the Buckingham North property, a graphite project located east of Ottawa/Gatineau. The company was formerly known as Matica Graphite Inc. and changed its name to Matica Enterprises Inc. in July 2014. Matica Enterprises Inc. is headquartered in Toronto, Canada.ZomedicaNYSEAMERICAN:ZOMZomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.